However, some tumors, including colorectal cancer, have been reported to show an increased expression of eotaxins [267], which indicates the potential benefits of immunotherapy in which anti-tumor cells will have an increased expression of CCR3, a receptor for eotaxins [267]. Here, CCL11 is linked to neoplasm.